Allergan, Inc. v. Lupin Ltd. et al
Allergan, Inc. |
Lupin Pharmaceuticals, Inc. and Lupin Ltd. |
2:2011cv00530 |
December 30, 2011 |
US District Court for the Eastern District of Texas |
Marshall Office |
Anderson |
David Folsom |
Patent |
35 U.S.C. ยง 271 |
Plaintiff |
Available Case Documents
The following documents for this case are available for you to view or download:
Document Text |
---|
Filing 124 MEMORANDUM OPINION and ORDER - The Court adopts the constructions set forth in this opinion for the disputed terms of the 338 and 982 patents. There are no disputed terms for the 215 patent. Within thirty (30) days of the issuance of this Memorandum Opinion and Order, the parties are hereby ORDERED, in good faith, to mediate this case with David Folsom, the mediator appointed in this case. Signed by Judge Rodney Gilstrap on 8/20/13. (ehs, ) |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Texas Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.